ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

DCT Advisors OK Recompetition Of Drug Contacts

March 15, 1991

Congress Mandates NIH Cut PR Costs, Coordinate Spending on Communications

January 31, 2014

NCI Advisory Group, Other Cancer Meetings

July 29, 1983

NI Communications Effort, Saves By Congress, Now A Major National Cancer Program Resource

August 15, 1975

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution

November 1, 1974